Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Completed 7Terminated 4Unknown 3Withdrawn 2Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 4NIH 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Genitourinary 1

Conditions

Stomach Neoplasms 2Small Cell Lung Carcinoma 1Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × OTHER × vistusertib × Clear all
NCT03061708 2019-05-20

AZD2014

Samsung Medical Center

Phase 2 Terminated
1 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03082833 2019-05-20

Phase II Trial of AZD2014 in TSC1/2 Mutated or TSC1/2 Null GC Patients as Second-line Chemotherapy

Samsung Medical Center

Phase 2 Terminated
1 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03106155 2018-09-20

[SUKSES-D]

Samsung Medical Center

Phase 2 Terminated
4 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT01793636 2014-06-24

ZEBRA

Queen Mary University of London

Phase 2 Terminated
49 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡